Usefulness of [ 18F]-DA and [ 18F]-DOPA for PET imaging in a mouse model of pheochromocytoma

Nuclear Medicine and Biology

Volumn 39, Issue 2, 2012, Pages 215-226

  Martiniova, Lucia ^a,j   Cleary, Susannah ^b   Lai, Edwin W ^a   Kiesewetter, Dale O ^c   Seidel, Jurgen ^d   Dawson, Linda F ^e   Phillips, Jacqueline K ^e,f   Thomasson, David ^g   Chen, Xiaoyuan ^c   Eisenhofer, Graeme ^h   Powers, James F ⁱ   Kvetnansky, Richard ^j   Pacak, Karel ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e MURDOCH UNIVERSITY   (Australia)

^f MACQUARIE UNIVERSITY   (Australia)

^g NATIONAL INSTITUTES OF HEALTH   (United States)

^h DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

ⁱ TUFTS MEDICAL CENTER   (United States)

^j INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

more..

Author keywords

Fluorodopa; Fluorodopamine; Metastatic mice model; MicroCT; MRI; Norepinephrine transporter; PET; Pheochromocytoma; Vesicular monoamine transporter

Indexed keywords

6 FLUORODOPA F 18; 6 FLUORODOPAMINE F 18; NORADRENALIN TRANSPORTER; VESICULAR MONOAMINE TRANSPORTER 1; VESICULAR MONOAMINE TRANSPORTER 2; 6 FLUORODOPAMINE; 6-FLUORODOPAMINE; CONTRAST MEDIUM; DIAGNOSTIC AGENT; DOPA; DOPAMINE; DRUG DERIVATIVE; VESICULAR MONOAMINE TRANSPORTER;

ADRENAL GLAND; ADRENAL METASTASIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELL VACUOLE; CONTROLLED STUDY; DISEASE MODEL; DRUG BINDING; DRUG RETENTION; DRUG UPTAKE; FEASIBILITY STUDY; FEMALE; HISTOPATHOLOGY; IMPLANTATION; KIDNEY; LIVER METASTASIS; LUNG METASTASIS; METASTASIS; MICRO-COMPUTED TOMOGRAPHY; MOUSE; MUSCLE TISSUE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY; OVARY METASTASIS; PHEOCHROMOCYTOMA; PHEOCHROMOCYTOMA CELL; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; SUBCUTANEOUS METASTASIS; SUBCUTANEOUS TISSUE; TUMOR VOLUME; ADRENAL TUMOR; ANIMAL; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; EXPERIMENTAL NEOPLASM; LIVER TUMOR; LUNG TUMOR; METABOLISM; METHODOLOGY; OVARY TUMOR; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TUMOR RECURRENCE;

ADRENAL GLAND NEOPLASMS; ANIMALS; CONTRAST MEDIA; DIHYDROXYPHENYLALANINE; DOPAMINE; FEMALE; LIVER NEOPLASMS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MICE; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, EXPERIMENTAL; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; OVARIAN NEOPLASMS; PHEOCHROMOCYTOMA; POSITRON-EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 84856340250     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2011.07.007     Document Type: Article

References (44)

1. Pacak K., Koch C.A., Eisenhofer G. Current approaches and new advances in endocrine hypertension. Trends Endocrinol Metab 2002, 13:96-97.
2. Pacak K., Eisenhofer G., Goldstein D.S. Functional imaging of endocrine tumors: role of positron emission tomography. Endocr Rev 2004, 25:568-580.
3. Burnichon N., Rohmer V., Amar L., Herman P., Leboulleux S., Darrouzet V., Niccoli P., Gaillard D., Chabrier G., Chabolle F., Coupier I., Thieblot P., Lecomte P., Bertherat J., Wion-Barbot N., Murat A., Venisse A., Plouin P.F., Jeunemaitre X., Gimenez-Roqueplo A.P. The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. J Clin Endocrinol Metab 2009, 94:2817-2827.
4. John H., Ziegler W.H., Hauri D., Jaeger P. Pheochromocytomas: can malignant potential be predicted?. Urology 1999, 53:679-683.
5. Mougey A.M., Adler D.C. Neuroendocrine tumors: review and clinical update. Hospital Physician 2007, 51:12-20.
6. Goldstein D.S., Grossman E., Tamrat M., Chang P.C., Eisenhofer G., Bacher J., Kirk K.L., Bacharach S., Kopin I.J. Positron emission imaging of cardiac sympathetic innervation and function using 18F-6-fluorodopamine: effects of chemical sympathectomy by 6-hydroxydopamine. J Hypertens 1991, 9:417-423.
7. Goldstein D.S., Holmes C., Stuhlmuller J.E., Lenders J.W., Kopin I.J. 6-[18F]fluorodopamine positron emission tomographic scanning in the assessment of cardiac sympathoneural function-studies in normal humans. Clin Auton Res 1997, 7:17-29.
8. Hoegerle S., Altehoefer C., Ghanem N., Koehler G., Waller C.F., Scheruebl H., Moser E., Nitzsche E. Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors. Radiology 2001, 220:373-380.
9. Pacak K., Chrousos G.P., Koch C.A., Lenders J.W., Eisenhofer G. Pheochromocytoma: progress in diagnosis, therapy, and genetics. Adrenal Disorders 2001, 479-523. Humana Press, Totowa. A. Margioris, G.P. Chrousos (Eds.).
10. Pacak K., Eisenhofer G., Carrasquillo J.A., Chen C.C., Li S.T., Goldstein D.S. 6-[18F]fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of pheochromocytoma. Hypertension 2001, 38:6-8.
11. Eisenhofer G. The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines. Pharmacol Ther 2001, 91:35-62.
12. Arita M., Wada A., Takara H., Izumi F. Inhibition of 22Na influx by tricyclic and tetracyclic antidepressants and binding of [3H]imipramine in bovine adrenal medullary cells. J Pharmacol Exp Ther 1987, 243:342-348.
13. Eisenhofer G., Smolich J.J., Cox H.S., Esler M.D. Neuronal reuptake of norepinephrine and production of dihydroxyphenylglycol by cardiac sympathetic nerves in the anesthetized dog. Circulation 1991, 84:1354-1363.
14. Lashford L.S., Hancock J.P., Kemshead J.T. Meta-iodobenzylguanidine (mIBG) uptake and storage in the human neuroblastoma cell line SK-N-BE(2C). Int J Cancer 1991, 47:105-109.
15. Havekes B., Lai E.W., Corssmit E.P., Romijn J.A., Timmers H.J., Pacak K. Detection and treatment of pheochromocytomas and paragangliomas: current standing of MIBG scintigraphy and future role of PET imaging. Q J Nucl Med Mol Imaging 2008, 52:419-429.
16. Huynh T.T., Pacak K., Brouwers F.M., Abu-Asab M.S., Worrell R.A., Walther M.M., Elkahloun A.G., Goldstein D.S., Cleary S., Eisenhofer G. Different expression of catecholamine transporters in phaeochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2. Eur J Endocrinol 2005, 153:551-563.
17. Maurel A., Spreux-Varoquaux O., Amenta F., Tayebati S.K., Tomassoni D., Seguelas M.H., Parini A., Pizzinat N. Vesicular monoamine transporter 1 mediates dopamine secretion in rat proximal tubular cells. Am J Physiol 2007, 292:F1592-1598.
18. Martiniova L., Ohta S., Quion P. Anatomical and functional imaging of tumors in animal models: focus on pheochromocytoma. Ann N Y Acad Sci 2006, 1073:392-404.
19. Powers J.F., Evinger M.J., Tsokas P., Bedri S., Alroy J., Shahsavari M., Tischler A.S. Pheochromocytoma cell lines from heterozygous neurofibromatosis knockout mice. Cell Tissue Res 2000, 302:309-320.
20. Erickson J.D., Schafer M.K., Bonner T.I., Eiden L.E., Weihe E. Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. Proc Natl Acad Sci USA 1996, 93:5166-5171.
21. Weihe E., Schafer M.K., Erickson J.D., Eiden L.E. Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to endocrine cells and neurons in rat. J Mol Neurosci 1994, 5:149-164.
22. Eisenhofer G., Hovevey-Sion D., Kopin I.J., Miletich R., Kirk K.L., Finn R., Goldstein D.S. Neuronal uptake and metabolism of 2- and 6-fluorodopamine: false neurotransmitters for positron emission tomographic imaging of sympathetically innervated tissues. J Pharmacol Exp Ther 1989, 248:419-427.
23. Weber S.M., Peterson K.A., Durkee B., Qi C., Longino M., Warner T., Lee F.T., Weichert J.P. Imaging of murine liver tumor using microCT with a hepatocyte-selective contrast agent: accuracy is dependent on adequate contrast enhancement. J Surg Res 2004, 119:41-45.
24. Martiniova L., Kotys M.S., Thomasson D., Schimel D., Lai E.W., Bernardo M., Merino M.J., Powers J.F., Ruzicka J., Kvetnansky R., Choyke P.L., Pacak K. Noninvasive monitoring of a murine model of metastatic pheochromocytoma: a comparison of contrast-enhanced microCT and nonenhanced MRI. J Magn Reson Imaging 2009, 29:685-691.
25. Lee F.T., Chosy S.G., Naidu S.G., Goldfarb S., Weichert J.P., Bakan D.A., Kuhlman J.E., Tambeaux R.H., Sproat I.A. CT depiction of experimental liver tumors: contrast enhancement with hepatocyte-selective iodinated triglyceride versus conventional techniques. Radiology 1997, 203:465-470.
26. Bakan D.A., Longino M.A., Weichert J.P., Counsell R.E. Physicochemical characterization of a synthetic lipid emulsion for hepatocyte-selective delivery of lipophilic compounds: application to polyiodinated triglycerides as contrast agents for computed tomography. J Pharm Sci 1996, 85:908-914.
27. Seidel J. Resolution uniformity and sensitivity of the NIH ATLAS small animal PET scanner: comparison to simulated LSO scanners without depth-of-interaction capability. IEEE Trans Nuc Sci 2003, 50:1347-1350.
28. Toyama H., Ichise M., Liow J.S., Modell K.J., Vines D.C., Esaki T., Cook M., Seidel J., Sokoloff L., Green M.V., Innis R.B. Absolute quantification of regional cerebral glucose utilization in mice by 18F-FDG small animal PET scanning and 2-14C-DG autoradiography. J Nucl Med 2004, 45:1398-1405.
29. Woodard H.Q., Bigler R.E., Freed B. Letter: expression of tissue isotope distribution. J Nucl Med 1975, 16:958-959.
30. Aliaga A., Rousseau J.A., Cadorette J., Croteau E., van Lier J.E., Lecomte R., Benard F. A small animal positron emission tomography study of the effect of chemotherapy and hormonal therapy on the uptake of 2-deoxy-2-[F-18]fluoro-d-glucose in murine models of breast cancer. Mol Imaging Biol 2007, 9:144-150.
31. Keyes J.W. SUV: standard uptake or silly useless value?. J Nucl Med 1995, 36:1836-1839.
32. Eisenhofer G., Goldstein D.S., Stull R., Keiser H.R., Sunderland T., Murphy D.L., Kopin I.J. Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin Chem 1986, 32:2030-2033.
33. Cleary S., Brouwers F.M., Eisenhofer G., Pacak K., Christie D.L., Lipski J., McNeil A.R., Phillips J.K. Expression of the noradrenaline transporter and phenylethanolamine N-methyltransferase in normal human adrenal gland and phaeochromocytoma. Cell Tissue Res 2005, 322:443-453.
34. Kippenberger A.G., Palmer D.J., Comer A.M., Lipski J., Burton L.D., Christie D.L. Localization of the noradrenaline transporter in rat adrenal medulla and PC12 cells: evidence for its association with secretory granules in PC12 cells. J Neurochem 1999, 73:1024-1032.
35. McDonald J.W., Pilgram T.K. Nuclear expression of p53, p21 and cyclin D1 is increased in bronchioloalveolar carcinoma. Histopathology 1999, 34:439-446.
36. King K., Chen C.C., Alexopoulos D.K., Whatley M., Reynolds J.C., Patronas N., Ling A., Adams K.T., Xekouki P., Lando H., Stratakis C., Pacak K. Functional Imaging of SDHx-Related Head and Neck Paragangliomas: comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-d-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy. J. Clin Endocr Meatb 2011, July, [epub ahead of print] doi:10.1210/jc.2011-0333.
37. Timmers H.J., Chen C.C., Carrasquillo J.A., Whatley M., Ling A., Havekes B., Eisenhofer G., Martiniova L., Adams K.T., Pacak K. Comparison of 18F-fluoro-l-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 2009, 94:4757-4767.
38. Timmers H.J., Eisenhofer G., Carrasquillo J.A., Chen C.C., Whatley M., Ling A., Adams K.T., Pacak K. Use of 6-[18F]-fluorodopamine positron emission tomography (PET) as first-line investigation for the diagnosis and localization of non-metastatic and metastatic phaeochromocytoma (PHEO). Clin Endocrinol (Oxf) 2009, 71:11-17.
39. Timmers H.J., Hadi M., Carrasquillo J.A., Chen C.C., Martiniova L., Whatley M., Ling A., Eisenhofer G., Adams K.T., Pacak K. The effects of carbidopa on uptake of 6-18F-fluoro-l-DOPA in PET of pheochromocytoma and extraadrenal abdominal paraganglioma. J Nucl Med 2007, 48:1599-1606.
40. Dutton J., Copeland L.G., Playfer J.R., Roberts N.B. Measuring l-DOPA in plasma and urine to monitor therapy of elderly patients with Parkinson disease treated with l-DOPA and a dopa decarboxylase inhibitor. Clinical Chem 1993, 39:629-634.
41. Peter D., Liu Y., Sternini C., de Giorgio R., Brecha N., Edwards R.H. Differential expression of two vesicular monoamine transporters. J Neurosci 1995, 15:6179-6188.
42. Frey K.A., Koeppe R.A., Kilbourn M.R., Vander Borght T.M., Albin R.L., Gilman S., Kuhl D.E. Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging. Ann Neurol 1996, 40:873-884.
43. Gilman S., Koeppe R.A., Junck L., Little R., Kluin K.J., Heumann M., Martorello S., Johanns J. Decreased striatal monoaminergic terminals in multiple system atrophy detected with positron emission tomography. Ann Neurol 1999, 45:769-777.
44. Garber K. Realistic rodents? Debate grows over new mouse models of cancer. J Nation Cancer Institute 2006, 98:1176-1178.